MERAKI CAPITAL PTY LTD – Trademark Portfolio
Entity Type: 82
MERAKI CAPITAL PTY LTD has 5 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 4 are successfully registered — a 100% registration rate, with 1 application currently pending. The portfolio includes marks such as SLLS and SAN LUEUR. Filings span 4 Nice Classification classes, with the highest activity in Class 10 (Medical Apparatus) and Class 35 (Advertising & Business).
B47,
18-20 Edinburg Street Oakleigh South VIC 3167
Showing of trademarks Trademarks
Trademark Classifications
MERAKI CAPITAL PTY LTD's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does MERAKI CAPITAL PTY LTD have?
MERAKI CAPITAL PTY LTD has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending.
What trademark classes does MERAKI CAPITAL PTY LTD file in?
MERAKI CAPITAL PTY LTD files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are MERAKI CAPITAL PTY LTD's most well-known trademarks?
MERAKI CAPITAL PTY LTD's registered trademark portfolio includes well-known marks such as SLLS and SAN LUEUR. These are among 4 currently registered trademarks in the portfolio.
What is MERAKI CAPITAL PTY LTD's trademark registration success rate?
MERAKI CAPITAL PTY LTD has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.